课题基金 / 基金详情

IMMUNOLOGICAL ANALYSIS OF ANTICANCER MECHANISM TO HUMAN BLADDER CANCER OF BCG

IMMUNOLOGICAL ANALYSIS OF ANTICANCER MECHANISM TO HUMAN BLADDER CANCER OF BCG
卡介苗抗人膀胱癌机制的免疫学分析
批准号:
11671546
负责人:
YAMAMOTO Naoki
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

YAMAMOTO Naoki的其他基金

相似基金

相关文献

中文摘要
翻译
为探讨卡介苗(bovis bacillus Calmette-Guerin, BCG)抗尿道癌的作用机制,进行了以下实验我们证明卡介苗诱导人树突状细胞(DC)成熟。卡介苗可提高人未成熟DC细胞表面CD40、CD80、CD83和CD86的表达,其作用与肿瘤坏死因子α (tnf - α)相似体外刺激后,采用荧光活化细胞分选法(FACS)检测卡介苗活化T细胞分泌TNFalpha、干扰素γ、白细胞介素2 (IL-2)的细胞因子染色。卡介苗的再刺激不能促进细胞因子的分泌。我们分析了卡介苗灌注治疗上尿路原位癌(CIS)的疗效和安全性,对6例细胞学诊断为上尿路原位癌的患者进行了卡介苗灌注治疗,并在输尿管和膀胱之间逆行置管6f输尿管导管或8f留置JJ输尿管支架。平均随访22个月;所有患者均未死亡,上尿路尿液细胞学检查均为阴性42例膀胱CIS患者行膀胱内灌注BCG。随访6 ~ 116个月,膀胱内灌注卡介苗治疗膀胱CIS的有效率为81.0%。两名患者死于膀胱癌。42例患者中10例行全膀胱切除术,8例病理发现肌层浸润。
英文摘要
To analyze the mechanism of bovis bacillus Calmette-Guerin (BCG) against urithelial carcinoma, the following experiments were performed.1 We demonstrated that the BCG induces maturation of human dendritic cells (DC). Surface expression of CD40, CD80, CD83, and CD86 was increased by BCG on human immature DC, and the effect was similar to those of tumor necrosis factor alpha (TNF-alpha).2 Secretion of TNFalpha, interferon-gamma, interleukin-2 (IL-2) by BCG activated T cell was determined by intracellular cytokine staining with fluorescence-activated cell sorting (FACS) after ex vivo stimulation. Restimulation by BCG did not facilitate secretion of cytokines, .We analysed the efficacy and safety of BCG perfusion for carcinoma in situ (CIS)1 Treatment for CIS of the upper urinary tract, 6 patients with cytologically diagnosed CIS of the upper urinary tract were treated by BCG instillation via retrograde catheterization using a 6 F ureteric catheter or an 8 F indwelling JJ ureteric stent between the ureter and bladder. The mean follow-up was 22 months ; none of the patients died, and all were negative for cytology in urine collected from the upper urinary tracts.2 Forty-two patients with CIS of bladder underwent intravesical instillation of BCG.In the follow-up period from 6 to 116 months, the efficacy rate of intravesical BCG instillation for CIS of the bladder was 81.0%. Two patients died from the bladder cancer. Total cystectomy was performed in 10 of 42 patients, and pathological findings of muscle layer invasion were detected in 8 patients.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Nishino Y: "Bacillus calmette-Guerin instillation for carcinoma in situ of the upper urinary trad"BJU Int. 85(7). 799-801 (2000)
Nishino Y:“卡美特-盖林芽孢杆菌滴注治疗上尿路原位癌”BJU Int。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nishino Y,Yamamoto N et al: "Bacillus Calmetle-Guerin instillation for carcinoma in situ of the upper urinary troct"B J U International. 85(7). 799-801 (2000)
Nishino Y、Yamamoto N 等人:“卡梅特-格林芽孢杆菌滴注治疗上尿路原位癌”B J U International。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nishino Y,Yasuda M et al: "Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder.Gifu BCG Instillation Therapy Research Group]."癌と化学療法. 26(12). 18 (1999)
Nishino Y、Yasuda M 等:“卡介苗膀胱内滴注治疗膀胱原位癌。岐阜 BCG 滴注治疗研究组]。癌症与化疗。26(12)。18 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 6 条
    Regulation of HBs antigen expression in HBV genotype A infection
    The analysis and identification of bome marrow drived liver repair cell
    • 批准号:
      15K09005
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2015
    • 负责人:
      YAMAMOTO Naoki
    • 依托单位:
    Development of novel long non-coding RNA mediated DNA methylation editting system
    • 批准号:
      15H06657
    • 项目类别:
      Grant-in-Aid for Research Activity Start-up
    • 资助金额:
      $1.75万
    • 财政年份:
      2015
    • 负责人:
      YAMAMOTO Naoki
    • 依托单位:
    Application of chiral-specificity of amino acids on the novel development of antipsychotic drugs for schizophrenia
    海外基金